<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1134">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05146388</url>
  </required_header>
  <id_info>
    <org_study_id>21-00972</org_study_id>
    <nct_id>NCT05146388</nct_id>
  </id_info>
  <brief_title>Working With Doctors and Pharmacists to Help Parents Give Children's Liquid Medicines Safely</brief_title>
  <official_title>Leveraging the EHR to Promote Pharmacy Adoption of Dosing Best Practices and Reduce Parent Errors in Administering Pediatric Liquid Medications: A Health Literacy-Informed Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Food and Drug Administration (FDA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pre-/post-implementation study that will be performed with English- and&#xD;
      Spanish-speaking parents of children prescribed oral liquid medications (dose 10mL or less)&#xD;
      in the pediatric emergency room, outpatient general pediatric clinic, and pediatric&#xD;
      subspecialty clinics of 2 New York city hospital systems (NYU Langone Health - Brooklyn and&#xD;
      NYC Health+Hospitals - Bellevue Hospital). A total of 500 subjects will be recruited across&#xD;
      the 2 hospital systems, 250 pre-implementation and 250 post-implementation.&#xD;
&#xD;
      An EHR-based intervention that leverages electronic prescriptions (e-Rx's) to support optimal&#xD;
      pharmacy dispensing practices (maintenance of dosing instructions in mL-only on prescription&#xD;
      bottle labels and provision of optimal dosing tools) and reduce parent dosing errors will be&#xD;
      evaluated. This intervention will be built directly into the Epic electronic health record&#xD;
      (EHR). Prior to implementation, e-Rx's will be generated by the EHR in the usual fashion;&#xD;
      after implementation, e-Rx's will be generated by the EHR with instructions to the dispensing&#xD;
      pharmacy to: 1) keep the dosing instructions in mL-only, and 2) dispense a specific dosing&#xD;
      tool based on the amount prescribed. Subjects in the pre-implementation phase will receive&#xD;
      usual care. Subjects in the post implementation phase will receive e-Rx with the EHR-based&#xD;
      approach (Index visit (in-person), Day 0).&#xD;
&#xD;
      Pharmacy dispensing practices (related to maintenance of dosing instructions in mL-only on&#xD;
      prescription bottle labels and provision of optimal dosing tools) will also be assessed via&#xD;
      review of a photo of the medicine bottle label and a photo of dosing tool received (photo&#xD;
      taken by parents and sent to research staff (Visit 1 (via phone), Day 2-28). Medication&#xD;
      adherence, dosing and medication related issues (including healthcare utilization and adverse&#xD;
      events) will be assessed in person at subsequent follow-up visit (Visit 2 (in-person), within&#xD;
      8 weeks of index visit). Participants will also have the option of completing a virtual dose&#xD;
      assessment. If they choose to complete the virtual dose assessment, they will be randomized&#xD;
      to showing us how they measured medicine either by sending photos or demonstrating the dose&#xD;
      over video (Visit 3, within 4 weeks of visit 2). At 1 month post-index visit, an EHR review&#xD;
      will supplement the in-person interview in reviewing medication issues, including side&#xD;
      effects and adverse drug events (ADEs).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>At the time of assessing whether a parent made dosing errors, there will be two raters independently estimate dose volumes. Raters will be kept blinded to each other's estimated dose volumes when making their own estimate in order to minimize bias of primary endpoints.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Caregiver Dosing Error</measure>
    <time_frame>Week 8 (Visit 2)</time_frame>
    <description>Dosing error will be defined as &gt;20% deviation from the prescribed dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Caregiver Large Dosing Error</measure>
    <time_frame>Week 8 (Visit 2)</time_frame>
    <description>Large dosing error will be defined as &gt;40% deviation from the prescribed dose</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Liquid Medication Dosing Error</condition>
  <arm_group>
    <arm_group_label>Pre-Implementation - Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In pre-implementation phase, patient e-Rxs will be generated by the EHR in the usual fashion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-Implementation - EHR-Based Approach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EHR-Based Approach</intervention_name>
    <description>The intervention will be built directly into the EHR. E-prescriptions will be generated with pharmacy instructions for all prescription medications. The intervention will impart: 1) inclusion with e-Rx request for pharmacy to keep metric-only dosing on Rx label and 2) inclusion of guidance on the e-Rx requesting that the pharmacy give an optimal tool based on an algorithm. Algorithm for dosing tool recommendation -- 1) for a prescribed dose of &lt;= 1mL, optimal tool is 1mL syringe, 2) for &gt;1mL to 5mL, use a 5mL syringe, 3_ for &gt;5mL to 10mL, use 10mL syringe.</description>
    <arm_group_label>Post-Implementation - EHR-Based Approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Caregiver/Child&#xD;
&#xD;
          1. English or Spanish-speaking&#xD;
&#xD;
          2. Parent or legal guardian of a child prescribed a liquid medicine in the NYU Langone&#xD;
             Health - Brooklyn or Bellevue ED, general outpatient pediatric clinic, or specialty&#xD;
             care clinics&#xD;
&#xD;
          3. 18 years of age or older&#xD;
&#xD;
          4. Child ≥8y discharged home with a Rx for ≥1 daily liquid medication dose ≤10mL/2tsp,&#xD;
             for use as a chronic or short course (&lt;14 days) medication&#xD;
&#xD;
          5. Primary person who will administer child's medications&#xD;
&#xD;
          6. Access to a smartphone that can take photos and send/receive text messages&#xD;
&#xD;
          7. Willingness and ability to participate&#xD;
&#xD;
        Pharmacy staff&#xD;
&#xD;
        1. Works at a pharmacy that dispensed index medicine to one of our study participants.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Caregiver/Child&#xD;
&#xD;
          1. Does not have a working phone number&#xD;
&#xD;
          2. Not able to return for in-person follow-up visit&#xD;
&#xD;
          3. Was told to stop medication by provider after doctor/ED visit&#xD;
&#xD;
          4. Parent no longer having index medication bottle&#xD;
&#xD;
          5. Uncorrected hearing impairment&#xD;
&#xD;
          6. Self-reported poor visual acuity&#xD;
&#xD;
        Pharmacy staff&#xD;
&#xD;
        1. Staff with no responsibility in determining unit of measure to include on Rx's or type&#xD;
        and capacity of the dosing tool to dispense for pediatric oral liquid medications.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>H. Shonna Yin, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>H. Shonna Yin, MD, MS</last_name>
    <phone>212-562-2821</phone>
    <email>Hsiang.Yin@nyulangone.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Melgar, MBS</last_name>
    <phone>212-562-2821</phone>
    <email>Jennifer.Melgar@nyulangone.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NYU Langone Health - Brooklyn</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11220</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Jennifer Melgar, MBS</last_name>
      <email>Jennifer.Melgar@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>H. Shonna Yin, MD, MS</last_name>
      <email>Hsiang.Yin@nyulangone.org</email>
    </contact_backup>
    <investigator>
      <last_name>H. Shonna Yin, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunset Park Family Health Center at NYU Langone</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11220</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Jennifer Melgar, MBS</last_name>
      <email>Jennifer.Melgar@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>H. Shonna Yin, MD, MS</last_name>
      <email>Hsiang.Yin@nyulangone.org</email>
    </contact_backup>
    <investigator>
      <last_name>H. Shonna Yin, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYC Health + Hospitals / Bellevue</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexander Glick, MD, MS</last_name>
      <email>alexander.glick@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Alexander Glick, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benard Dreyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 23, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electronic Prescriptions (e-Rx)</keyword>
  <keyword>Pharmacy Dispensing Practices</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Hsiang.Yin@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

